查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1751202

口服固体製剂CDMO市场规模、份额、趋势分析报告：依产品、机制、治疗适应症、最终用途、地区、细分市场预测，2025-2030年

Oral Solid Dosage CDMO Market Size, Share & Trends Analysis Report By Product (Tablets, Capsules), By Mechanism (Immediate Release, Delayed Release), By Drug Potency, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 262 Pages | 商品交期: 2-10个工作天内

价格

口服固体製剂CDMO 市场的成长与趋势：

预计到 2030 年，全球口服固体製剂CDMO 市场规模将达到 635 亿美元，2025 年至 2030 年的复合年增长率为 6.49%。

製药公司和生物製药公司对口服固体製剂外包生产的需求日益增长，这迫使合约开发与受託製造厂商(CDMO) 扩大其生产设施，以满足製药公司的需求。此类扩建正在全球范围内进行，以提高其在口服固体製剂行业的渗透率。此外，作为口服固体製剂 (OSD) 产品的学名药数量也在增加，因此，对学名药日益增长的需求是市场成长的主要驱动力。

慢性病和感染疾病患者数量的不断增长是推动新型治疗药物需求的主要因素，从而对该行业的整体发展产生了积极影响。此外，老年人口的快速成长（老年人易患慢性病）以及老年族群局部外用药物（OSD）的高采用率，也进一步推动了OSD的需求。此外，现有药物的不良反应也推动了对新型治疗方案的需求，也促进了市场的成长。

口服固体製剂CDMO市场持续推动技术进步，以提高生产效率、产品品质和法规遵从性，进而对整体市场成长潜力产生正面影响。连续生产有助于无缝整合众多单元操作，从而简化生产工作流程，并提高口服固体製剂生产的灵活性。此外，层析法、光谱法、质谱法和溶离度测试等技术进步使CDMO能够提高药物分析的准确性、灵敏度和可靠性。此外，自动化、机器人技术和数据分析的整合简化了分析工作流程，缩短了周转时间，提高了数据完整性，并符合良好生产规范（GMP）和国际协调会议（ICH）指南等监管标准。

口服固体製剂CDMO市场报告重点

  • 从产品角度来看，锭剂领域将在 2024 年占据市场主导地位。该领域的高成长得益于研发活动投资的增加、製造流程的技术进步、创新的药物输送方式，以及对先进解决方案日益增长的需求，以满足高市场需求。
  • 根据机制，由于患者依从性提高、疗效和安全性增强以及给药频率降低，控制释放预计将在 2024 年占据最大的市场占有率。
  • 根据药物适应症，低效药物在 2024 年占据了最大的市场占有率，这是因为低效药物的开发和製造过程简单、对学名药的需求高，从而需要具有成本效益的解决方案、患者群体庞大以及渗透到多个治疗领域以实现有效的患者结果。
  • 根据最终用途，中小企业（SME）部门将占收益的大部分，到2024年将占比超过72.34%。该部门的成长归因于越来越多的中小企业将其生产业务外包给CDMO和CMO。中小企业在配方开发、製程优化和口服固体製剂生产方面的资源和能力有限。因此，客户越来越偏好CDMO来开发和生产口服固体製剂。
  • 预计到2024年，亚太地区将占据口服固体製剂CDMO市场的36.76%。越来越多的製药生产外包至包括印度和中国在内的亚洲国家。这导致该地区製药公司进行的临床研究数量增加。此外，充足的原材料供应和先进的製造基础设施预计将推动该地区市场的成长。

目录

第一章调查方法与范围

第二章执行摘要

第三章口服固体製剂CDMO 市场变数、趋势与范围

  • 市场展望
    • 母市场展望
    • 补贴市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 技术格局
    • 製造技术
    • 封装技术
    • 涂层技术
    • 包装技术
    • 分析技术
  • 定价模式分析
  • 口服固态製剂契约製造市场分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19影响分析

第四章口服固体製剂CDMO 市场：依产品分類的估算与趋势分析

  • 细分仪表板
  • 口服固体製剂CDMO市场：产品差异分析
  • 全球口服固体製剂CDMO 市场规模及趋势分析（依产品，2018-2030 年）
  • 药片
    • 压缩片
    • 口溶锭（ODT）
    • 咀嚼片
    • 双层或三层片剂
    • 舌下或颊片
    • 其他的
  • 胶囊
    • 硬明胶胶囊
    • 软胶囊
  • 粉末
  • 颗粒
  • 其他的

第五章口服固体製剂CDMO 市场：依机制的估计与趋势分析

  • 细分仪表板
  • 口服固体製剂CDMO市场：机制变异分析
  • 全球口服固体製剂CDMO 市场规模及趋势分析（按机制，2018-2030 年）
  • 即时释放
  • 延迟释放
  • 控释

第六章口服固体製剂CDMO 市场：按药物适应症的估计和趋势分析

  • 细分仪表板
  • 口服固体製剂CDMO市场：药物效力差异分析
  • 全球口服固体製剂CDMO 市场规模及趋势分析（依药品适应症，2018-2030 年）
  • 高效药物
  • 中等效力的药物
  • 低效药物

第七章口服固体製剂CDMO 市场：依最终用途的估算与趋势分析

  • 细分仪表板
  • 口服固体製剂CDMO市场：最终用途差异分析
  • 全球口服固体製剂CDMO 市场规模及趋势分析（依最终用途，2018-2030 年）
  • 大公司
  • 中小企业
  • 其他的

第 8 章口服固体製剂CDMO 市场：区域评估与趋势分析、按产品、按机制、按药物适应症、按最终用途

  • 区域仪表板
  • 口服固体製剂CDMO市场：区域差异分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 公司分类
    • 市场领导者
    • 新兴企业
  • 2024 年公司市场占有率/估值分析
  • 公司简介
    • Lonza
    • Thermo Fisher Scientific Inc.
    • Cambrex Corporation
    • Catalent Inc.
    • Siegrfried Holding AG
    • Recipharm AB
    • CordenPharma International
    • Boehringer Ingelheim
    • Piramal Pharma Solutions
    • Aenova Group
    • Almac Group
    • Jubilant Pharmova Limited
    • Delpharm
    • AbbVie Contract Manufacturing
    • Next Pharma AB
    • Rubicon Research Pvt. Ltd.
    • Quotient Sciences
    • Almac Group
    • SPI Pharma
    • DPT Laboratories Ltd.
    • Alcami Corporation
Product Code: GVR-4-68040-587-6

Oral Solid Dosage CDMO Market Growth & Trends:

The global oral solid dosage CDMO market size is expected to reach USD 63.50 billion by 2030, and grow at a CAGR of 6.49% from 2025 to 2030. The increasing demand for outsourcing oral solid dosage manufacturing among pharmaceutical and biopharmaceutical companies has compelled contract development and manufacturing organizations (CDMO) to expand their manufacturing facilities to support the demand of pharmaceutical companies. These expansions are made across the globe to enhance their oral solid dosage industry penetration. Furthermore, the rising demand for generic drugs is a key factor for the market growth as there are increasing numbers of generics as OSD products.

The growing number of patients suffering from chronic and infectious diseases is key factor driving demand for novel therapeutics, thereby positively influencing overall industry progression. In addition, Booming geriatric population that are highly prone to chronic diseases and high adoption rate of OSD among this population further supporting the demand for OSD. Furthermore, another factor contributing to the market growth is adverse drug reactions to existing drugs, which have increased the demand for novel treatment options.

Ongoing technological advancements in the oral solid dosage CDMO market to enhance manufacturing efficiency, product quality, and regulatory compliance are positively influencing overall market growth potential. Continuous manufacturing assists seamless integration of numerous unit operations leading to streamlined production workflows and increased flexibility in manufacturing oral solid dosage forms. Moreover, innovations in techniques such as chromatography, spectroscopy, mass spectrometry, and dissolution testing enabled CDMOs to meet enhanced precision, sensitivity, & reliability in pharmaceutical analysis. Furthermore, the integration of automation, robotics, & data analytics streamlined analytical workflows, reduced turnaround times, and enhanced data integrity & compliance with regulatory standards such as Good Manufacturing Practices (GMP) & International Council for Harmonization (ICH) guidelines.

Oral Solid Dosage CDMO Market Report Highlights:

  • Basd on product, the tablets segment dominated the market in 2024. The high segment growth is driven by increasing investment in research and development activities, technological advancements in manufacturing processes, innovative drug delivery options and the growing need for advanced solutions to cater to high market demand.
  • Based on the mechanism, controlled release segment held the largest market share in 2024 attributing to an improved patient compliance, enhanced efficacy & safety, and reduced frequency of administration.
  • Based on the drug potency, low potent drugs segment held the largest market share in 2024 owing to ease of development and manufacturing processes, high demand for generic drugs coupled with need for cost effective solutions, high patient population and high penetration among multiple therapeutic areas to cater effective patient outcome.
  • Based on end use, medium & small-size companies segment held the majority revenue share, accounting for over 72.34% in 2024. Growth in the segment can be attributed to the increasing number of small- & medium-sized companies outsourcing their production work to CDMOs and CMOs. Medium and small-sized pharmaceutical companies have limited resources and capabilities in formulation development, process optimization, and manufacturing of oral solid dosage forms. Thus, growing customer preference towards CDMOs for the development and manufacturing of oral solid dosage.
  • Asia Pacific dominated the oral solid dosage CDMO market with a share of 36.76% in 2024. The outsourcing of pharmaceutical manufacturing to Asian countries, including India and China, has increased due to their lower costs and availability of potential study subjects. This has led to an increase in clinical studies conducted by pharmaceutical companies in the region. Moreover, high availability of raw materials and advanced manufacturing infrastructure will propel regional market growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value Chain-Based Sizing & Forecasting (Model 2)
    • 1.7.3. QFD Model Sizing & Forecasting (Model 3)
    • 1.7.4. Bottom-up Approach (Model 4)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. List of Abbreviations
  • 1.11. Objectives
    • 1.11.1. Objective 1
    • 1.11.2. Objective 2
    • 1.11.3. Objective 3
    • 1.11.4. Objective 4

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Oral Solid Dosage CDMO Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technological Advancements in Oral Solid Dosage (OSD) Forms
      • 3.2.1.2. Expansion of Manufacturing Capacity by CMOs & CDMOs for OSD
      • 3.2.1.3. Increasing Demand for Novel Therapies
      • 3.2.1.4. Increasing Demand for One-Stop-Shop CMOs
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Strict Approval Criteria by Regulatory Authorities
      • 3.2.2.2. Lack of Experienced Technical Staff, Physical Capability, and Equipment Capacity
      • 3.2.2.3. Increasing Need for Biosimilars and Their Prominence in Addressing Cancer & Other Medical Conditions
  • 3.3. Technology Landscape
    • 3.3.1. Manufacturing Technology
    • 3.3.2. Encapsulation Technology
    • 3.3.3. Coating Technology
    • 3.3.4. Packaging Technology
    • 3.3.5. Analytical Technology
  • 3.4. Pricing Model Analysis
  • 3.5. Oral Solid Dosage Contract Manufacturing Market Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Oral Solid Dosage CDMO Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Oral Solid Dosage CDMO Market: Product Movement Analysis
  • 4.3. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Tablets
    • 4.4.1. Tablets Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Compressed Tablets
      • 4.4.2.1. Compressed Tablets Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Orally Disintegrating Tablets (ODT)
      • 4.4.3.1. Orally Disintegrating Tablets (ODT) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Chewable Tablets
      • 4.4.4.1. Chewable Tablets Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Bi-layer or Tri-layer Tablets
      • 4.4.5.1. Bi-layer or Tri-layer Tablets Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. Sublingual or Buccal Tablets
      • 4.4.6.1. Sublingual or Buccal Tablets Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.7. Others
      • 4.4.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Capsules
    • 4.5.1. Capsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Hard Gelatin Capsules
      • 4.5.2.1. Hard Gelatin Capsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Soft Gelatin Capsules
      • 4.5.3.1. Soft Gelatin Capsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Powder
    • 4.6.1. Powder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Granules
    • 4.7.1. Granules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Oral Solid Dosage CDMO Market: Mechanism Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Oral Solid Dosage CDMO Market: Mechanism Movement Analysis
  • 5.3. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Mechanism, 2018 to 2030 (USD Million)
  • 5.4. Immediate Release
    • 5.4.1. Immediate Release Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Delayed Release
    • 5.5.1. Delayed Release Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Controlled Release
    • 5.6.1. Controlled Release Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Oral Solid Dosage CDMO Market: Drug Potency Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Oral Solid Dosage CDMO Market: Drug Potency Movement Analysis
  • 6.3. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Drug Potency, 2018 to 2030 (USD Million)
  • 6.4. High Potent Drugs
    • 6.4.1. High Potent Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Moderate Potent Drugs
    • 6.5.1. Moderate Potent Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Low Potent Drugs
    • 6.6.1. Low Potent Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Oral Solid Dosage CDMO Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Oral Solid Dosage CDMO Market: End Use Movement Analysis
  • 7.3. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Large Size Companies
    • 7.4.1. Large Size Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Medium & Small Size Companies
    • 7.5.1. Medium & Small Size Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Oral Solid Dosage CDMO Market: Regional Estimates & Trend Analysis, by Product, by Mechanism, by Drug Potency, by End Use

  • 8.1. Regional Dashboard
  • 8.2. Oral Solid Dosage CDMO Market: Regional Movement Analysis
  • 8.3. North America
    • 8.3.1. North America Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Australia Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Thailand Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. South Korea
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. South Korea Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Middle East & Africa
    • 8.7.1. Middle East & Africa Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Saudi Arabia Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. UAE Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Company Market Share/Assessment Analysis, 2024
  • 9.3. Company Profiles
    • 9.3.1. Lonza
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product/Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Thermo Fisher Scientific Inc.
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product/Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Cambrex Corporation
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product/Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Catalent Inc.
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product/Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Siegrfried Holding AG
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product/Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Recipharm AB
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product/Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. CordenPharma International
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product/Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Boehringer Ingelheim
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product/Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Piramal Pharma Solutions
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product/Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Aenova Group
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product/Service Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Almac Group
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Product/Service Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. Jubilant Pharmova Limited
      • 9.3.12.1. Company Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Product/Service Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. Delpharm
      • 9.3.13.1. Company Overview
      • 9.3.13.2. Financial Performance
      • 9.3.13.3. Product/Service Benchmarking
      • 9.3.13.4. Strategic Initiatives
    • 9.3.14. AbbVie Contract Manufacturing
      • 9.3.14.1. Company Overview
      • 9.3.14.2. Financial Performance
      • 9.3.14.3. Product/Service Benchmarking
      • 9.3.14.4. Strategic Initiatives
    • 9.3.15. Next Pharma AB
      • 9.3.15.1. Company Overview
      • 9.3.15.2. Financial Performance
      • 9.3.15.3. Product/Service Benchmarking
      • 9.3.15.4. Strategic Initiatives
    • 9.3.16. Rubicon Research Pvt. Ltd.
      • 9.3.16.1. Company Overview
      • 9.3.16.2. Financial Performance
      • 9.3.16.3. Product/Service Benchmarking
      • 9.3.16.4. Strategic Initiatives
    • 9.3.17. Quotient Sciences
      • 9.3.17.1. Company Overview
      • 9.3.17.2. Financial Performance
      • 9.3.17.3. Product/Service Benchmarking
      • 9.3.17.4. Strategic Initiatives
    • 9.3.18. Almac Group
      • 9.3.18.1. Company Overview
      • 9.3.18.2. Financial Performance
      • 9.3.18.3. Product/Service Benchmarking
      • 9.3.18.4. Strategic Initiatives
    • 9.3.19. SPI Pharma
      • 9.3.19.1. Company Overview
      • 9.3.19.2. Financial Performance
      • 9.3.19.3. Product/Service Benchmarking
      • 9.3.19.4. Strategic Initiatives
    • 9.3.20. DPT Laboratories Ltd.
      • 9.3.20.1. Company Overview
      • 9.3.20.2. Financial Performance
      • 9.3.20.3. Product/Service Benchmarking
      • 9.3.20.4. Strategic Initiatives
    • 9.3.21. Alcami Corporation
      • 9.3.21.1. Company Overview
      • 9.3.21.2. Financial Performance
      • 9.3.21.3. Product/Service Benchmarking
      • 9.3.21.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 5 Global Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 6 Global Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 7 Global Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 8 Global Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 9 Global Oral Solid Dosage CDMO Market, by Region, 2018 - 2030 (USD Million)
  • Table 10 North America Oral Solid Dosage CDMO Market, by Country, 2018 - 2030 (USD Million)
  • Table 11 North America Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 12 North America Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 13 North America Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 14 North America Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 15 North America Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 16 North America Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 U.S Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 18 U.S Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 19 U.S Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 20 U.S Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 21 U.S Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 22 U.S Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 23 Canada Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 24 Canada Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 25 Canada Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 26 Canada Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 27 Canada Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 28 Canada Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 29 Mexico Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 30 Mexico Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 31 Mexico Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 32 Mexico Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 33 Mexico Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 34 Mexico Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 35 Europe Oral Solid Dosage CDMO Market, by Country, 2018 - 2030 (USD Million)
  • Table 36 Europe Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 37 Europe Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 38 Europe Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 39 Europe Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 40 Europe Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 41 Europe Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Germany Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 43 Germany Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 44 Germany Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 45 Germany Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 46 Germany Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 47 Germany Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 48 UK Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 49 UK Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 50 UK Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 51 UK Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 52 UK Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 53 UK Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 54 France Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 55 France Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 56 France Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 57 France Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 58 France Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 59 France Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 60 Italy Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 61 Italy Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 62 Italy Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 63 Italy Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 64 Italy Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 65 Italy Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 66 Spain Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 67 Spain Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 68 Spain Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 69 Spain Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 70 Spain Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 71 Spain Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 72 Denmark Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 73 Denmark Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 74 Denmark Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 75 Denmark Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 76 Denmark Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 77 Denmark Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 78 Sweden Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 79 Sweden Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 80 Sweden Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 81 Sweden Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 82 Sweden Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 83 Sweden Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 84 Norway Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 85 Norway Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 86 Norway Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 87 Norway Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 88 Norway Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 89 Norway Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 90 Asia Pacific Oral Solid Dosage CDMO Market, by Country, 2018 - 2030 (USD Million)
  • Table 91 Asia Pacific Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 92 Asia Pacific Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 93 Asia Pacific Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 94 Asia Pacific Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 95 Asia Pacific Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 96 Asia Pacific Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 97 China Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 98 China Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 99 China Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 100 China Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 101 China Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 102 China Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 103 Japan Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 104 Japan Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 105 Japan Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 106 Japan Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 107 Japan Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 108 Japan Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 109 India Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 110 India Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 111 India Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 112 India Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 113 India Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 114 India Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 115 South Korea Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 116 South Korea Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 117 South Korea Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 118 South Korea Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 119 South Korea Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 120 South Korea Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 121 Australia Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 122 Australia Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 123 Australia Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 124 Australia Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 125 Australia Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 126 Australia Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 127 Thailand Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 128 Thailand Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 129 Thailand Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 130 Thailand Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 131 Thailand Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 132 Thailand Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 133 Latin America Oral Solid Dosage CDMO Market, by Country, 2018 - 2030 (USD Million)
  • Table 134 Latin America Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 135 Latin America Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 136 Latin America Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 137 Latin America Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 138 Latin America Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 139 Latin America Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 140 Brazil Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 141 Brazil Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 142 Brazil Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 143 Brazil Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 144 Brazil Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 145 Brazil Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 146 Argentina Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 147 Argentina Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 148 Argentina Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 149 Argentina Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 150 Argentina Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 151 Argentina Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 152 Middle East & Africa Oral Solid Dosage CDMO Market, by Country, 2018 - 2030 (USD Million)
  • Table 153 Middle East & Africa Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 154 Middle East & Africa Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 155 Middle East & Africa Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 156 Middle East & Africa Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 157 Middle East & Africa Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 158 Middle East & Africa Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 159 South Africa Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 160 South Africa Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 161 South Africa Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 162 South Africa Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 163 South Africa Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 164 South Africa Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 165 Saudi Arabia Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 166 Saudi Arabia Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 167 Saudi Arabia Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 168 Saudi Arabia Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 169 Saudi Arabia Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 170 Saudi Arabia Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 171 UAE Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 172 UAE Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 173 UAE Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 174 UAE Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 175 UAE Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 176 UAE Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 177 Kuwait Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 178 Kuwait Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 179 Kuwait Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 180 Kuwait Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 181 Kuwait Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 182 Kuwait Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Oral Solid Dosage CDMO, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Regional Marketplace: Key Takeaways
  • Fig. 12 Global Oral Solid Dosage CDMO, for Tablets, 2018 - 2030 (USD Million)
  • Fig. 13 Global Oral Solid Dosage CDMO, for Compressed Tablets, 2018 - 2030 (USD Million)
  • Fig. 14 Global Oral Solid Dosage CDMO, for Orally Disintegrating Tablets (ODT), 2018 - 2030 (USD Million)
  • Fig. 15 Global Oral Solid Dosage CDMO, for Chewable Tablets, 2018 - 2030 (USD Million)
  • Fig. 16 Global Oral Solid Dosage CDMO, for Bi-layer or Tri-layer Tablets, 2018 - 2030 (USD Million)
  • Fig. 17 Global Oral Solid Dosage CDMO, for Sublingual or Buccal Tablets, 2018 - 2030 (USD Million)
  • Fig. 18 Global Oral Solid Dosage CDMO, for Others, 2018 - 2030 (USD Million)
  • Fig. 19 Global Oral Solid Dosage CDMO, for Hard Gelatin Capsules, 2018 - 2030 (USD Million)
  • Fig. 20 Global Oral Solid Dosage CDMO, for Soft Gelatin Capsules, 2018 - 2030 (USD Million)
  • Fig. 21 Global Oral Solid Dosage CDMO, for Immediate Release, 2018 - 2030 (USD Million)
  • Fig. 22 Global Oral Solid Dosage CDMO, for Delayed Release, 2018 - 2030 (USD Million)
  • Fig. 23 Global Oral Solid Dosage CDMO, for Controlled Release, 2018 - 2030 (USD Million)
  • Fig. 24 Global Oral Solid Dosage CDMO, for High Potent Drugs, 2018 - 2030 (USD Million)
  • Fig. 25 Global Oral Solid Dosage CDMO, for Moderate Potent Drugs, 2018 - 2030 (USD Million)
  • Fig. 26 Global Oral Solid Dosage CDMO, for Low Potent Drugs, 2018 - 2030 (USD Million)
  • Fig. 27 Global Oral Solid Dosage CDMO, for Large Size Companies, 2018 - 2030 (USD Million)
  • Fig. 28 Global Oral Solid Dosage CDMO, for Medium & Small Size Companies, 2018 - 2030 (USD Million)
  • Fig. 29 Global Oral Solid Dosage CDMO, for Others, 2018 - 2030 (USD Million)
  • Fig. 30 Regional Outlook, 2023 & 2030
  • Fig. 31 North America Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Europe Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Germany Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 France Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Spain Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Norway Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Japan Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 China Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 India Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Australia Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 UAE Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)